Predicting Biologic Therapy Outcome of Patients With Spondyloarthritis: Joint Models for Longitudinal and Survival Analysis
BackgroundRheumatic diseases are one of the most common chronic diseases worldwide. Among them, spondyloarthritis (SpA) is a group of highly debilitating diseases, with an early onset age, which significantly impacts patients’ quality of life, health care systems, and society...
Main Authors: | Carolina Barata, Ana Maria Rodrigues, Helena Canhão, Susana Vinga, Alexandra M Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-07-01
|
Series: | JMIR Medical Informatics |
Online Access: | https://medinform.jmir.org/2021/7/e26823 |
Similar Items
-
Zgli: A Pipeline for Clustering by Compression with Application to Patient Stratification in Spondyloarthritis
by: Diogo Azevedo, et al.
Published: (2023-01-01) -
Coupling sparse Cox models with clustering of longitudinal transcriptomics data for trauma prognosis
by: Cláudia S. Constantino, et al.
Published: (2021-04-01) -
Quality of life in spondyloarthritis patients receiving biological therapy
by: A. I. Akulova, et al.
Published: (2019-10-01) -
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
by: Isidoro González-Álvaro, et al.
Published: (2017-11-01) -
Kidney Cancer Biomarker Selection Using Regularized Survival Models
by: Carolina Peixoto, et al.
Published: (2022-07-01)